Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023
Introduction COVID-19 vaccines may be administered with other vaccines during the same healthcare visit. COVID-19 monovalent (Fall 2021) and bivalent (Fall 2022) vaccine recommendations coincided with annual seasonal influenza vaccination. Data describing the frequency of the co-administration of CO...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2361946 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849717191855833088 |
|---|---|
| author | Casey E. Parker Anne M. Hause Paige Marquez Bicheng Zhang Tanya R. Myers David K. Shay |
| author_facet | Casey E. Parker Anne M. Hause Paige Marquez Bicheng Zhang Tanya R. Myers David K. Shay |
| author_sort | Casey E. Parker |
| collection | DOAJ |
| description | Introduction COVID-19 vaccines may be administered with other vaccines during the same healthcare visit. COVID-19 monovalent (Fall 2021) and bivalent (Fall 2022) vaccine recommendations coincided with annual seasonal influenza vaccination. Data describing the frequency of the co-administration of COVID-19 vaccines with other vaccines are limited. Methods We used V-safe, a voluntary smartphone-based U.S. safety surveillance system established by the CDC, to describe trends in the administration of COVID-19 vaccines with other vaccines reported to V-safe during December 14, 2020 – May 19, 2023. Results Of the 21 million COVID-19 vaccinations reported to V-safe, 2.2% (459,817) were administered with at least 1 other vaccine. Co-administration most frequently occurred during the first week of October 2023 (27,092; 44.1%). Most reports of co-administration included influenza vaccine (393,003; 85.5%). Co-administration was most frequently reported for registrants aged 6 months-6 years (4,872; 4.4%). Conclusion Reports of co-administration to V-safe peaked during October 2023, when influenza vaccination most often occurs, possibly reflecting increased opportunities for multiple vaccinations and greater acceptability of the co-administration of COVID-19 vaccine with other vaccines, especially influenza vaccine. |
| format | Article |
| id | doaj-art-eec475062d8349339ac3d89d097f006d |
| institution | DOAJ |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-eec475062d8349339ac3d89d097f006d2025-08-20T03:12:43ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2361946Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023Casey E. Parker0Anne M. Hause1Paige Marquez2Bicheng Zhang3Tanya R. Myers4David K. Shay5Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAImmunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAImmunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAImmunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAImmunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAImmunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAIntroduction COVID-19 vaccines may be administered with other vaccines during the same healthcare visit. COVID-19 monovalent (Fall 2021) and bivalent (Fall 2022) vaccine recommendations coincided with annual seasonal influenza vaccination. Data describing the frequency of the co-administration of COVID-19 vaccines with other vaccines are limited. Methods We used V-safe, a voluntary smartphone-based U.S. safety surveillance system established by the CDC, to describe trends in the administration of COVID-19 vaccines with other vaccines reported to V-safe during December 14, 2020 – May 19, 2023. Results Of the 21 million COVID-19 vaccinations reported to V-safe, 2.2% (459,817) were administered with at least 1 other vaccine. Co-administration most frequently occurred during the first week of October 2023 (27,092; 44.1%). Most reports of co-administration included influenza vaccine (393,003; 85.5%). Co-administration was most frequently reported for registrants aged 6 months-6 years (4,872; 4.4%). Conclusion Reports of co-administration to V-safe peaked during October 2023, when influenza vaccination most often occurs, possibly reflecting increased opportunities for multiple vaccinations and greater acceptability of the co-administration of COVID-19 vaccine with other vaccines, especially influenza vaccine.https://www.tandfonline.com/doi/10.1080/21645515.2024.2361946COVID-19 vaccineinfluenza vaccineco-administrationV-safe |
| spellingShingle | Casey E. Parker Anne M. Hause Paige Marquez Bicheng Zhang Tanya R. Myers David K. Shay Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 Human Vaccines & Immunotherapeutics COVID-19 vaccine influenza vaccine co-administration V-safe |
| title | Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 |
| title_full | Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 |
| title_fullStr | Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 |
| title_full_unstemmed | Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 |
| title_short | Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023 |
| title_sort | trends in the administration of covid 19 vaccines with other vaccines in the united states reported to v safe during december 14 2020 may 19 2023 |
| topic | COVID-19 vaccine influenza vaccine co-administration V-safe |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2361946 |
| work_keys_str_mv | AT caseyeparker trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 AT annemhause trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 AT paigemarquez trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 AT bichengzhang trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 AT tanyarmyers trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 AT davidkshay trendsintheadministrationofcovid19vaccineswithothervaccinesintheunitedstatesreportedtovsafeduringdecember142020may192023 |